Today

Agents

Chat

Arena

Discover

More

App

Acumen Pharmaceuticals announces virtual investor day meeting - ABOS News | Rallies

Acumen Pharmaceuticals announces virtual investor day meeting

ABOS•2026-09-10

Virtual investor day planned for September 16

Acumen Pharmaceuticals will hold a virtual Investor Day meeting on September 16, 2026, in a virtual setting.
Management is set to present updates on the company’s Alzheimer’s disease pipeline, including sabirnetug (ACU193) and the ALTITUDE-AD Phase 2 program.

Related News

BRIEF-Friedman Industries Enters Seventh Amendment To Credit Agreement On Sept 3, 2026 - SEC Filing

FRD•2026-09-10

Hepion Pharmaceuticals votes reverse stock split of 1-for-20 to 1-for-50

HEPA•2026-09-10

Barington Takes New Stake In Bath & Body Works, Pushing For Sale - Bloomberg News

BBWI

•

2026-09-10

Dell Technologies launches $5 billion senior notes offering

DELL•2026-09-10

D-Wave Quantum files prospectus for resale of 7,095,721 shares by US Commerce Department

QBTS•2026-09-10